Your browser doesn't support javascript.
loading
Prediction of Early Periprosthetic Joint Infection After Total Hip Arthroplasty.
Bülow, Erik; Hahn, Ute; Andersen, Ina Trolle; Rolfson, Ola; Pedersen, Alma B; Hailer, Nils P.
Afiliação
  • Bülow E; The Swedish Arthroplasty Register, Centre of Registers Västra Götaland, Gothenburg, Sweden.
  • Hahn U; Department of Orthopaedics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Andersen IT; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Rolfson O; Department of Mathematics, Aarhus University, Aarhus, Denmark.
  • Pedersen AB; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
  • Hailer NP; The Swedish Arthroplasty Register, Centre of Registers Västra Götaland, Gothenburg, Sweden.
Clin Epidemiol ; 14: 239-253, 2022.
Article em En | MEDLINE | ID: mdl-35281208
Purpose: To develop a parsimonious risk prediction model for periprosthetic joint infection (PJI) within 90 days after total hip arthroplasty (THA). Patients and Methods: We used logistic LASSO regression with bootstrap ranking to develop a risk prediction model for PJI within 90 days based on a Swedish cohort of 88,830 patients with elective THA 2008-2015. The model was externally validated on a Danish cohort with 18,854 patients. Results: Incidence of PJI was 2.45% in Sweden and 2.17% in Denmark. A model with the underlying diagnosis for THA, body mass index (BMI), American Society for Anesthesiologists (ASA) class, sex, age, and the presence of five defined comorbidities had an area under the curve (AUC) of 0.68 (95% CI: 0.66 to 0.69) in Sweden and 0.66 (95% CI: 0.64 to 0.69) in Denmark. This was superior to traditional models based on ASA class, Charlson, Elixhauser, or the Rx Risk V comorbidity indices. Internal calibration was good for predicted probabilities up to 10%. Conclusion: A new PJI prediction model based on easily accessible data available before THA was developed and externally validated. The model had superior discriminatory ability compared to ASA class alone or more complex comorbidity indices and had good calibration. We provide a web-based calculator (https://erikbulow.shinyapps.io/thamortpred/) to facilitate shared decision making by patients and surgeons.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Epidemiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia País de publicação: Nova Zelândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Epidemiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia País de publicação: Nova Zelândia